MRNS marinuspharma.com Sof daromad

Marinus Pharmaceuticals, Inc. (MRNS) kompaniyasining rasmiy ramzlari

Marinus Pharmaceuticals (MRNS) logistik uzilishlarni minimallashtirish uchun nevrologik dori vositalari ishlab chiqarishini AQSh va Yevropadagi sertifikatlangan CMOga topshirdi. Kompaniyaning ushbu grafikdagi sof foydasi tushumlar dinamikasini aks ettiradi, bunda -0.14 joriy ko'rsatkichni tashkil etadi. Ztalmy preparatining epilepsiya davolash protokollariga integratsiyasi noyob tibbiy ekotizimni yaratadi, shifokorlar orasidagi yuqori obro' esa ushbu biotexnologiya kompaniyasining pragmatik maqomini tasdiqlaydi.

Marinus Pharma (MRNS) Kompaniyaning sof foydasi: 04.07.2022 - 22.02.2025 davri uchun

Marinus Pharmaceuticals, Inc. (MRNS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Marinus Pharma|MRNS - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Marinus Pharma|MRNS - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga balans qiymati Marinus Pharmaceuticals|MRNS - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati marinuspharma.com|MRNS - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Marinus Pharmaceuticals Inc|MRNS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Marinus Pharma|MRNS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Marinus Pharmaceuticals|Oraliq qoplash koeffitsiyenti marinuspharma.com
- foyda va bozor multiplikatorlari tafsilotlari:
MRNS - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Marinus Pharmaceuticals
Marinus Pharma seriyali mahsuloti

Investorlar Marinus Pharmaceuticals (MRNS) kompaniyasining barqarorligini barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyingi yakuniy moliyaviy natijani aks ettiruvchi sof foyda dinamikasi orqali bahlamoqdalar. Kompaniyaning sof rentabelligini tahlil qilish bozor talabini shartnomaviy quvvatlardan foydalanishning haqiqiy samaradorligi va o'z qadoqlash liniyalarini modernizatsiya qilish bilan solishtirish imkonini beradi, bu esa joriy sanoat sikli doirasida aktivning fundamental qiymatini belgilaydi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Sof daromad regencellbioscience.com (RGC)|Sof foyda AXSM|Sof foyda ACADIA Pharma (ACAD)|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|Supernus Pharmaceuticals - Sof foyda|Sof moliyaviy natija catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniya foydasi HRMY|Sof daromad BHVN|Sof foyda Amylyx Corp|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|Sof moliyaviy natija praxismedicines.com|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda ALEC|ANNX: Sof foyda|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Sof foyda AC Immune S.A.|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Yakuniy foyda|Kompaniyaning sof foydasi Scilex Holding Company SCLX|TVGN - Sof daromad|Alpha Cognition Corp - Sof foyda|CGTX - Sof foyda|IKT: Sof foyda|Sof daromad Cassava Pharma|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad VTGN (Vistagen Therapeutics)|Sof foyda ovidrx.com (OVID)|Acumen Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda CRVO (CervoMed Corporation)|Alterity Therapeutics Ltd - Sof foyda|Sof moliyaviy natija Clene Inc. CLNN|PEPG: Sof foyda|Sof daromad jupiterneurosciences.com|RLMD (Relmada) - Sof foyda|Sof foyda Annovis Bio Corporation|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Kompaniyaning sof foydasi AIFF (fireflyneuro.com)|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|RVPH - Kompaniyaning sof foydasi|MetaVia Inc (MTVA) - Sof daromad|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Helius Medical Technologies - Yakuniy foyda|Kompaniyaning sof foydasi Passage Bio Inc.|Kompaniya foydasi NEUP (Neuphoria)|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|Sof moliyaviy natija Athira Pharma Corp|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|Cyclerion - Sof foyda|Kompaniyaning sof daromadi Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Sof daromad|Cortigent (CRGT) - Sof foyda|Kompaniyaning sof foydasi Avenue Therapeutics|BCLI: Yakuniy foyda|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|CHRO - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Eliem Therapeutics Inc. ELYM|ITCI - Sof daromad|Longboard Pharmaceuticals - Sof foyda|NKGN - Sof foyda|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sage Therapeutics Inc. - Yakuniy foyda|SNPX (Neurotrope) - Sof foyda|Trevena Inc (TRVN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Anew Medical Inc. - Kompaniya foydasi|Cerevel Therapeutics, Inc. - Sof daromad